Medication info
Nuvorozet Tablets 40/5/10/10 Milligrams

Nuvorozet Tablets 40/5/10/10 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tabletRosuvastatin Calcium Micronized›10.4mg / 1 tabletEzetimibe›10mg / 1 tabletS-Amlodipine Besylate Dihydrate›7.38mg / 1 tablet
Manufacturer / importer
Jonggeun Dang Co., Ltd.
Appearance
Pale green oval film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202203012 · Approved 2022.07.20 · Insurance code 643309110

Summary

Main use
Treatment of hypertension and dyslipidemia (hypercholesterolemia and mixed dyslipidemia)
Who takes it
Adults
Adult dose
This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/S-amlodipine (amlodipine) combination and the rosuvastatin/ezetimibe combination. The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). Take this medicine whole; do not chew, divide, or crush it. ○ Telmisartan/S-amlodipine (amlodipine) The recommended dose of the telmisartan/S-amlodipine (amlodipine) combination is once daily. Before administering the telmisartan/S-amlodipine (amlodipine) combination, it is recommended that the dose be adjusted using the individual components (telmisartan or S-amlodipine (amlodipine)). However, if blood pressure is not controlled with the individual components, switching directly to the telmisartan/S-amlodipine (amlodipine) combination may be considered as follows. - 40/2.5 mg: For patients whose blood pressure is not adequately controlled with S-amlodipine 2.5 mg (amlodipine 5 mg) or telmisartan 40 mg. - 80/2.5 mg: For patients whose blood pressure is not adequately controlled with S-amlodipine 2.5 mg (amlodipine 5 mg). - 40/5 mg: For patients whose blood pressure is not adequately controlled with telmisartan 40 mg or 80 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with telmisartan 80 mg or this medicine 40/5 mg. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: In older adults aged 75 years or older, treatment should be initiated at a low dose and the dose increased gradually because amlodipine clearance is reduced. ○ Rosuvastatin/ezetimibe Primary hypercholesterolemia The dosage range of the rosuvastatin/ezetimibe combination is 5/10 mg∼20/10 mg once daily. The recommended initial dose is 5/10 mg once daily. The dose may be adjusted in patients who require a greater reduction in LDL cholesterol. After starting treatment with the rosuvastatin/ezetimibe combination or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased up to a maximum of 20/10 mg daily. For patients taking the telmisartan/S-amlodipine (amlodipine) combination and the rosuvastatin/ezetimibe combination concomitantly, they may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.

Ingredients

Manufacturer
Jonggeun Dang Co., Ltd.

Efficacy & effects

Treatment of hypertension and dyslipidemia (hypercholesterolemia and mixed dyslipidemia)

  • Essential hypertension
  • primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated Apo B protein
  • elevated triglycerides
  • elevated non-HDL cholesterol
View approved original text

This medication is used when patients with both hypertension and dyslipidemia who are already taking telmisartan and S-amlodipine combination therapy and rosuvastatin and ezetimibe combination therapy require additional blood pressure and cholesterol control. It is particularly effective when essential hypertension is not adequately controlled with telmisartan or S-amlodipine monotherapy. Additionally, it is used as an adjunct to diet in patients with primary hypercholesterolemia or both familial and non-familial hypercholesterolemia, and mixed dyslipidemia to reduce total cholesterol, LDL cholesterol, Apo B, triglycerides, and non-HDL cholesterol, and to increase HDL cholesterol. This medication helps to improve blood pressure and blood lipid levels simultaneously.

How to take

Adult dose

This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/S-amlodipine (amlodipine) combination and the rosuvastatin/ezetimibe combination. The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). Take this medicine whole; do not chew, divide, or crush it. ○ Telmisartan/S-amlodipine (amlodipine) The recommended dose of the telmisartan/S-amlodipine (amlodipine) combination is once daily. Before administering the telmisartan/S-amlodipine (amlodipine) combination, it is recommended that the dose be adjusted using the individual components (telmisartan or S-amlodipine (amlodipine)). However, if blood pressure is not controlled with the individual components, switching directly to the telmisartan/S-amlodipine (amlodipine) combination may be considered as follows. - 40/2.5 mg: For patients whose blood pressure is not adequately controlled with S-amlodipine 2.5 mg (amlodipine 5 mg) or telmisartan 40 mg. - 80/2.5 mg: For patients whose blood pressure is not adequately controlled with S-amlodipine 2.5 mg (amlodipine 5 mg). - 40/5 mg: For patients whose blood pressure is not adequately controlled with telmisartan 40 mg or 80 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with telmisartan 80 mg or this medicine 40/5 mg. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: In older adults aged 75 years or older, treatment should be initiated at a low dose and the dose increased gradually because amlodipine clearance is reduced. ○ Rosuvastatin/ezetimibe Primary hypercholesterolemia The dosage range of the rosuvastatin/ezetimibe combination is 5/10 mg∼20/10 mg once daily. The recommended initial dose is 5/10 mg once daily. The dose may be adjusted in patients who require a greater reduction in LDL cholesterol. After starting treatment with the rosuvastatin/ezetimibe combination or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased up to a maximum of 20/10 mg daily. For patients taking the telmisartan/S-amlodipine (amlodipine) combination and the rosuvastatin/ezetimibe combination concomitantly, they may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.

Precautions

This medication can cause serious harm to the fetus, especially during the second and third trimesters of pregnancy, and should be discontinued immediately upon confirmation of pregnancy. Muscle-related side effects may occur rarely; if symptoms such as myalgia, weakness, or cramping occur, notify a physician immediately. This medication should not be used in patients with certain liver diseases or severe liver dysfunction, and regular liver function tests are required. Patients with severe kidney dysfunction or certain kidney diseases should also avoid this medication. Caution is needed when administering this medication in cases of severely low blood pressure or serious heart disease. This medication may elevate potassium levels in the blood, so caution is necessary in patients with high potassium levels or those taking drugs that can raise potassium levels. Dizziness or drowsiness may occur while taking this medication, so caution is advised when driving or operating hazardous machinery. Patients with certain genetic disorders or lactose intolerance should not take this medication. There may be interactions with other medications, so be sure to inform healthcare professionals of any other medications being taken. This medication can affect liver and kidney function, thus regular blood tests and health evaluations are needed. If any unusual symptoms such as muscle pain or weakness, rash, swelling occur, consult a healthcare professional immediately.

Side effects

  • Increased ALT
  • Increased AST
  • Increased Ɣ-GTP
  • Edema
  • Orthostatic hypotension
  • Hyperkalemia
  • Facial edema
  • Strange sensation
  • Drug intolerance
  • Colonic polyps
Show 194 more
  • Irritable bowel syndrome
  • Esophagitis
  • Dizziness
  • Somnolence
  • Neurodegenerative disorders
  • Positional dizziness
  • Migraine
  • Diabetes
  • Impaired glucose tolerance
  • Depression
  • Bronchitis
  • Rhinitis
  • Cystitis
  • Onychomycosis
  • Soft tissue infection
  • Hepatic steatosis
  • Liver dysfunction
  • Hepatotoxicity
  • Acute hepatitis
  • Toxic hepatitis
  • Increased gamma-glutamyl transferase
  • Increased blood cholesterol
  • Increased serum alkaline phosphatase
  • Irregular heartbeat
  • Osteoarthritis
  • Osteoporosis
  • Musculoskeletal rigidity
  • Musculoskeletal discomfort
  • Muscle weakness
  • Diaphoresis
  • Dermatitis
  • Skin burning sensation
  • Skin disorders
  • Alopecia
  • Oropharyngeal pain
  • Nasal congestion
  • Respiratory distress
  • Pelvic pain
  • Breast cysts
  • Eyelid drooping
  • Diabetic retinopathy
  • Ear discomfort
  • Renal dysfunction
  • Benign esophageal neoplasm
  • Upper respiratory tract infection
  • Urinary tract infection
  • Sepsis
  • Anemia
  • Thrombocytopenia
  • Eosinophilia
  • Hypersensitivity
  • Anaphylactic reaction
  • Hypoglycemia
  • Insomnia
  • Anxiety
  • Syncope
  • Visual disturbances
  • Dizziness
  • Bradycardia
  • Tachycardia
  • Hypotension
  • Shortness of breath
  • Abdominal pain
  • Diarrhea
  • Dyspepsia
  • Abdominal bloating
  • Vomiting
  • Abdominal discomfort
  • Xerostomia
  • Abnormal liver function
  • Liver disorder
  • Increased sweating
  • Pruritus
  • Rash
  • Erythema
  • Angioedema
  • Drug rash
  • Toxic skin rash
  • Eczema
  • Urticaria
  • Myalgia
  • Back pain
  • Muscle cramps
  • Arthralgia
  • Limb pain
  • Tendon pain
  • Acute renal failure
  • Chest pain
  • Asthenia
  • Influenza-like illness
  • Increased serum creatinine
  • Increased serum uric acid
  • Elevated creatine kinase
  • Decreased hemoglobin
  • Headache
  • Facial spasm
  • Sensory abnormalities
  • Paralysis
  • Cough
  • Hyperventilation
  • Pneumonia
  • Flushing
  • Erectile dysfunction
  • Anorexia
  • Arrhythmia
  • Weakness
  • Decreased libido
  • Facial swelling
  • Alopecia
  • Conjunctivitis
  • Tinnitus
  • Petechiae
  • Pancreatitis
  • Erythema multiforme
  • Maculopapular rash
  • Heaviness
  • Warm sensation
  • Impaired glucose tolerance
  • Weakness
  • Constipation
  • Changes in bowel habits
  • Gingival hyperplasia
  • Xerostomia
  • Pancreatitis
  • Vomiting
  • Hyperglycemia
  • Hyperactivity
  • Sensory loss
  • Peripheral neuropathy
  • Taste abnormalities
  • Tremors
  • Extrapyramidal disorder
  • Erectile dysfunction
  • Gynecomastia
  • Increased urinary frequency
  • Urinary dysfunction
  • Nocturia
  • Hepatitis
  • Jaundice
  • Elevated liver enzyme levels
  • Pruritus
  • Hyperhidrosis
  • Purpura
  • Urticaria
  • Toxic epidermal necrolysis
  • Myocardial infarction
  • Arrhythmia
  • Chest pain
  • Blood pressure drop
  • Sinoatrial block
  • Atrioventricular block
  • Precordial pain
  • Diarrhea
  • Loose stools
  • Constipation
  • Erythema multiforme
  • Maculopapular rash
  • Headache
  • Dizziness
  • Constipation
  • Nausea
  • Myalgia
  • Myopathy
  • Rhabdomyolysis
  • Asthenia
  • Arthralgia
  • Joint pain
  • Numbness
  • Sensory abnormalities
  • Chest discomfort
  • Anorexia
  • Abdominal bloating
  • Abnormal liver function tests
  • Syncope
  • Generalized pain
  • Muscle cramps
  • Gout
  • Erectile dysfunction
  • Anaphylaxis
  • Urticaria
  • Rash
  • Angioedema
  • Erythema multiforme
  • Myalgia
  • Elevated creatine phosphokinase
  • Myopathy
  • Rhabdomyolysis
  • Elevated liver aminotransferases
  • Hepatitis
  • Abdominal pain
  • Thrombocytopenia
  • Nausea
  • Cholelithiasis
  • Cholecystitis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, and it is safest to store it at room temperature between 1 to 30 degrees Celsius. Storing it this way will help maintain the effectiveness of the medication for a longer period.

Appearance and packaging

Appearance

Pale green oval film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.